AbbVie Inc. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) shed 0.07% to $144.42 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.06% to 3,719.89 and Dow Jones Industrial Average falling 0.46% to 32,001.25. This was the stock's second consecutive day of losses. AbbVie Inc. closed $31.49 short of its 52-week high ($175.91), which the company reached on April 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Pfizer Inc. (PFE) fell 0.21% to $46.57, Eli Lilly & Co. (LLY) rose 1.89% to $361.68, and AstraZeneca PLC ADR (AZN.LN) rose 0.39% to $59.93. Trading volume (3.9 M) remained 1.7 million below its 50-day average volume of 5.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 3, 2022.
(END) Dow Jones Newswires
November 03, 2022 16:33 ET (20:33 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.